
Interview with Robin Mansukhani CEO and Anil Bhushan Chief Scientist of Deciduous Therapeutics
07/19/22 • 29 min
Deciduous Therapeutics is a venture-backed startup developing novel immunotherapies to treat age-related diseases.
Deciduous Therapeutics is a venture-backed startup developing novel immunotherapies to treat age-related diseases.
Previous Episode

Interview with Dr. Viktor Mayer-Schonberger Professor of Internet Governance and Regulation at Oxford
Professor Viktor Mayer-Schönberger of Internet Governance and Regulation at Oxford. His research focuses on the role of information in a networked economy. Earlier he spent ten years on the faculty of Harvard’s Kennedy School of Government.
Next Episode

Interview with David Ewalt Editor in Chief of Gizmodo
David Ewalt, Editor in Chief of Gizmodo
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/innovating-with-scott-amyx-184847/interview-with-robin-mansukhani-ceo-and-anil-bhushan-chief-scientist-o-22128492"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to interview with robin mansukhani ceo and anil bhushan chief scientist of deciduous therapeutics on goodpods" style="width: 225px" /> </a>
Copy